CC
SGYP

Callan Capital’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Callan Capital’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-150,100
Closed -$1.25M – 75
2015
Q2 		$1.25M Sell
150,100
-111,122
-43% -$539K 0.26% 40
2015
Q1 		$1.21M Buy
261,222
+19,877
+8% +$64.6K 0.26% 39
2014
Q4 		$736K Buy
241,345
+123,145
+104% +$364K 0.17% 48
2014
Q3 		$329K Sell
118,200
-14,000
-11% -$50.8K 0.09% 55
2014
Q2 		$538K Buy
132,200
+122,200
+1,222% +$519K 0.14% 46
2014
Q1 		$53K Sell
10,000
-140
-1% -$785 0.02% 51
2013
Q4 		$56K Buy
+10,140
New +$43.7K 0.02% 47

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Callan Capital's SGYP Position: Q3 2015 in Review

Callan Capital sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2015, closing a stake of 150,100 shares — an estimated $1.25M sold.

Callan Capital first reported a position in SGYP in Q4 2013 and held it in 7 quarters. The position peaked at $1.25M in Q2 2015. 129 funds tracked by Wall St. Rank hold SGYP as of Q3 2015.

  • Callan Capital reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2015 after selling out during the quarter.
  • Callan Capital sold 150,100 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2015, an estimated $1.25M.
  • Callan Capital first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2013 and held it in 7 quarters.
  • Callan Capital's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.25M in Q2 2015.
  • 129 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2015.

Based on Callan Capital's 13F filing for Q3 2015, filed 10 Nov 2015.